MoonLake Immunotherapeutics
MLTX53.560USD
+0.640+1.21%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
3.40BMarket Cap
LossP/E TTM
MoonLake Immunotherapeutics
53.560
+0.640+1.21%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Operating expenses
139.58%47.48M
229.90%49.58M
232.23%43.11M
131.90%30.58M
53.27%19.82M
-9.99%15.03M
-12.14%12.98M
-25.30%13.19M
-18.89%12.93M
16.94%16.70M
135.68%14.77M
-45.99%17.65M
--15.94M
--14.28M
--6.27M
--32.68M
R&D expenses
180.15%36.46M
398.40%40.36M
371.13%35.74M
171.86%23.66M
75.51%13.01M
-28.77%8.10M
-15.95%7.59M
-23.65%8.70M
-29.08%7.42M
127.72%11.37M
1247.88%9.02M
-61.83%11.40M
--10.45M
--4.99M
--669.53K
--29.87M
Depreciation, depletion, and amortization
1556.95%378.00K
39464.88%1.30M
888.30%32.52K
754.73%28.11K
593.40%22.81K
0.00%3.29K
-0.09%3.29K
0.03%3.29K
32.23%3.29K
32.25%3.29K
45.00%3.29K
--3.29K
--2.49K
--2.49K
--2.27K
----
Other operating expenses
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
----
Operating profit
-139.58%-47.48M
-229.90%-49.58M
-232.23%-43.11M
-131.90%-30.58M
-53.27%-19.82M
9.99%-15.03M
12.14%-12.98M
25.30%-13.19M
18.89%-12.93M
-16.94%-16.70M
-135.68%-14.77M
45.99%-17.65M
---15.94M
---14.28M
---6.27M
---32.68M
Net non-operating interest income (expenses)
Non-operating interest expense
--18.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
19.98%7.10M
-55.11%3.23M
411.41%7.09M
599.95%5.90M
717.48%5.92M
2900.28%7.19M
3587.69%1.39M
243.76%842.65K
941.05%723.59K
765.13%239.50K
280.39%37.59K
6584.92%245.13K
--69.51K
---36.01K
---20.84K
---3.78K
Income before tax
-190.58%-40.41M
-491.02%-46.35M
-210.79%-36.02M
-99.95%-24.68M
-13.90%-13.91M
52.34%-7.84M
21.33%-11.59M
29.09%-12.34M
23.09%-12.21M
-14.98%-16.46M
-134.30%-14.73M
46.74%-17.41M
---15.87M
---14.31M
---6.29M
---32.69M
Income tax
117.79%153.00K
-7.15%41.14K
218.45%92.11K
675.61%78.70K
538.07%70.25K
302.36%44.31K
230.93%28.92K
9.32%10.15K
50.16%11.01K
131.59%11.01K
--8.74K
--9.28K
--7.33K
--4.75K
--0.00
--0.00
Income after tax
-190.21%-40.56M
-488.23%-46.40M
-210.81%-36.11M
-100.42%-24.76M
-14.38%-13.98M
52.10%-7.89M
21.18%-11.62M
29.07%-12.35M
23.05%-12.22M
-15.01%-16.47M
-134.44%-14.74M
46.72%-17.42M
---15.88M
---14.32M
---6.29M
---32.69M
Net income from continuous operations
-190.21%-40.56M
-488.23%-46.40M
-210.81%-36.11M
-100.42%-24.76M
-14.38%-13.98M
52.10%-7.89M
21.18%-11.62M
29.07%-12.35M
23.05%-12.22M
-15.01%-16.47M
-134.44%-14.74M
46.72%-17.42M
---15.88M
---14.32M
---6.29M
---32.69M
Other net gains and losses
----
----
----
----
----
----
----
---2.00
----
----
----
----
----
----
----
----
Net Income attributable to non-controlling interests
-103.73%-615.00K
-75.70%-791.19K
66.99%-724.09K
77.79%-491.74K
90.61%-301.87K
96.90%-450.31K
---2.19M
---2.21M
---3.21M
---14.53M
----
----
----
----
----
----
Net income attributable to controlling interests
-192.12%-39.94M
-513.20%-45.60M
-275.45%-35.39M
-139.34%-24.27M
-51.85%-13.67M
-284.32%-7.44M
36.06%-9.43M
41.78%-10.14M
43.29%-9.00M
86.48%-1.94M
-134.44%-14.74M
46.72%-17.42M
---15.88M
---14.32M
---6.29M
---32.69M
Net income attributable to common shareholders
-192.12%-39.94M
-513.20%-45.60M
-275.45%-35.39M
-139.34%-24.27M
-51.85%-13.67M
-284.32%-7.44M
36.06%-9.43M
41.78%-10.14M
43.29%-9.00M
86.48%-1.94M
-134.44%-14.74M
46.72%-17.42M
---15.88M
---14.32M
---6.29M
---32.69M
Basic earnings per share
-189.37%-0.63
-483.68%-0.72
-219.46%-0.56
-66.51%-0.39
5.31%-0.22
-155.79%-0.12
55.88%-0.18
53.15%-0.23
46.40%-0.23
87.51%-0.05
-134.44%-0.40
44.11%-0.49
---0.43
---0.39
---0.17
---0.89
Diluted earnings per share
-189.37%-0.63
-483.68%-0.72
-219.46%-0.56
-66.51%-0.39
5.31%-0.22
-155.79%-0.12
55.88%-0.18
53.15%-0.23
46.40%-0.23
87.51%-0.05
-134.44%-0.40
44.11%-0.49
---0.43
---0.39
---0.17
---0.89
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
